Whitehawk Therapeutics (WHWK) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for Whitehawk Therapeutics (WHWK) over the last 7 years, with Q3 2025 value amounting to $373000.0.
- Whitehawk Therapeutics' Accumulated Depreciation & Amortization fell 1033.65% to $373000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $373000.0, marking a year-over-year decrease of 1033.65%. This contributed to the annual value of $193000.0 for FY2024, which is 1420.12% up from last year.
- Whitehawk Therapeutics' Accumulated Depreciation & Amortization amounted to $373000.0 in Q3 2025, which was down 1033.65% from $368000.0 recorded in Q2 2025.
- Over the past 5 years, Whitehawk Therapeutics' Accumulated Depreciation & Amortization peaked at $416000.0 during Q3 2024, and registered a low of $38000.0 during Q1 2023.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $142000.0 (2022), whereas its average is $192875.0.
- In the last 5 years, Whitehawk Therapeutics' Accumulated Depreciation & Amortization plummeted by 4864.86% in 2023 and then soared by 60400.0% in 2025.
- Whitehawk Therapeutics' Accumulated Depreciation & Amortization (Quarter) stood at $105000.0 in 2021, then skyrocketed by 51.43% to $159000.0 in 2022, then rose by 6.29% to $169000.0 in 2023, then grew by 14.2% to $193000.0 in 2024, then skyrocketed by 93.26% to $373000.0 in 2025.
- Its Accumulated Depreciation & Amortization stands at $373000.0 for Q3 2025, versus $368000.0 for Q2 2025 and $352000.0 for Q1 2025.